Modernatx, Inc.

This study tested the Moderna COVID-19 vaccine in over 4,300 healthy adolescents aged 12 to under 18. The goal was to see if the vaccine is safe and works as well in teens as it does in young adults. Participants received the main vaccine series, a booster, and an updated version…

This study tested updated mRNA COVID-19 vaccines in over 1,800 children aged 6 months to under 6 years. The goal was to see if these vaccines are safe and boost immunity against newer virus variants. The vaccines were given as a first series or as a booster shot.

This study tested a new vaccine called mRNA-1083 that aims to protect against both flu and COVID-19 in a single shot. About 1,320 healthy adults aged 18 to 64 took part. Researchers measured the immune response and checked for side effects to see if the combo vaccine works as wel…

This study tested a new mRNA-based flu vaccine (mRNA-1010) in 172 healthy adults aged 18-50 and 65-80. Researchers compared its safety and ability to boost immunity against standard flu vaccines. The goal is to see if this new approach can offer better protection against seasonal…

This study looked at how long a vaccine for cytomegalovirus (CMV) stays effective in adults. It included 135 people who had already received the vaccine in an earlier study. Some participants also got a booster dose to see if it safely improves protection.

This large study tested a new mRNA-based seasonal flu vaccine (mRNA-1010) in over 40,000 adults aged 50 and older. The goal was to see if it works better than the standard flu shot at preventing flu-like illness and to check its safety. Participants received either the new mRNA v…

This study tested an experimental mRNA vaccine (mRNA-1345) to protect against RSV, a common respiratory virus that can be serious in older adults. About 3,300 people aged 50 and older received the RSV vaccine alone, with a flu shot, or with a COVID-19 booster. Researchers monitor…

This study tested an experimental mRNA vaccine (mRNA-1345) against RSV in 360 pregnant women. The goal was to see if the vaccine is safe for mothers and their babies, and whether it can pass protection to newborns. Participants received either the vaccine or a placebo between wee…

This study tested a new COVID-19 vaccine (mRNA-1283) to see if it works as well as or better than the current vaccine (mRNA-1273) in preventing COVID-19. Over 13,500 people aged 12 and older took part. Researchers measured immune response and safety, aiming to improve protection …

This study tested a single shot vaccine called mRNA-1083 that aims to protect against both COVID-19 and the flu. About 932 adults aged 50 to 64 took part. Researchers checked how safe the vaccine was and how well it boosted the body's defenses against both viruses.

This study tested a new vaccine called mRNA-1083 that aims to protect against both COVID-19 and the flu with a single shot. It involved about 2,400 healthy adults aged 50 and older in Japan, Taiwan, and South Korea. Researchers measured how well the vaccine boosted antibodies and…

This study tested a new combination mRNA vaccine from Moderna that targets both flu and COVID-19 in one shot. About 1,758 healthy adults took part to see if the vaccine is safe and triggers a strong immune response. The goal was to find the best dose and formula for future larger…

This study tested an experimental mRNA vaccine (mRNA-1647) to see if it is safe and can help the body fight cytomegalovirus (CMV), a common virus that can cause serious problems in newborns and people with weak immune systems. About 873 healthy volunteers aged 9 to 25 took part, …

This study tested an experimental mRNA vaccine (mRNA-1647) to see if it is safe and can trigger an immune response against cytomegalovirus (CMV), a common virus that can cause serious problems in newborns and people with weak immune systems. The trial involved 315 healthy adults …

This study tested the safety and immune response of several Moderna mRNA vaccines for COVID-19, seasonal flu, RSV, and CMV in 308 healthy adults aged 18 to 75. Researchers monitored side effects and measured antibody levels after vaccination. The goal was to ensure the vaccines a…

This study tested an experimental mRNA vaccine (mRNA-1893) to prevent Zika virus, a mosquito-borne disease that can cause serious birth defects. About 800 healthy adults aged 18 to 65 received either the vaccine or a placebo. Researchers checked for side effects and measured the …

This study tested an experimental mRNA vaccine (mRNA-1608) in 303 healthy adults aged 18 to 55 with recurrent genital herpes caused by HSV-2. The goal was to see if the vaccine is safe and can reduce the number of outbreaks. Participants received different doses of the vaccine or…

This study looked at whether a booster shot of the mRNA-1345 vaccine is safe and boosts immunity in adults aged 60 and older who had received a licensed RSV vaccine at least 12 months earlier. About 507 medically stable participants received the booster. Researchers monitored sid…

This study looked at whether an updated mRNA COVID-19 vaccine causes a rise in a heart enzyme called troponin, which can signal heart stress. About 1000 healthy volunteers aged 12 to 30 received either the vaccine or a placebo, then switched groups later. Researchers measured tro…